Tag Archives: lab-on-a-chip

Electrokinetic device enables noninvasive point-of-care testing from biofluids Leyla Esfandiari, University of Cincinnati assistant professor of electrical and biomedical engineering, has created...

A new ultrasensitive diagnostic device could allow doctors to detect cancer quickly from a droplet of blood or plasma, leading to timelier interventions...

There is growing awareness for the need of early diagnostic tools to aid in point-of-care testing in cancer. Tumor biopsy remains the conventional means in which to sample a tumor and often presents with challenges and associated risks. Therefore...

Exosomes, the smallest sized extracellular vesicles (∽30-150 nm) packaged with lipids, proteins, functional messenger RNAs and microRNAs, and double-stranded DNA from their cells of origin, have emerged as key players in intercellular communication. Their presence in bodily fluids, where they ...

Biological Dynamics announced the publication of data in ACS Nano demonstrating that the company’s proprietary lab-on-a-chip ExoVerita™ system can simplify and streamline the process for isolation and recovery of exosomes. The company is using this technology to develop a portfolio ...

from The Gaurdian by Gustavo Stolovitzky – The sooner a disease is diagnosed, the more likely it is to be well managed or cured. The challenge to finding a disease early is that most of us don’t seek treatment until ...

For the last decade, IBM has asked its brain trust of scientists and researchers to pick the five hottest of the hot technologies on the cusp of broad adoption. This year’s 5 in 5 list focuses on how advances in ...

from Delaware Public Media by Katie Peikes – Scientists say it’s hard to detect premature evidence of cancer with existing technology, but a University of Delaware professor is developing a better early warning system. John Slater, a professor of biomedical ...

IBM scientists will collaborate with the Icahn School of Medicine at Mount Sinai to test on prostate cancer IBM (NYSE: IBM) scientists have developed a new lab-on-a-chip technology that can, for the first time, separate biological particles at the nanoscale ...

Tumor-derived circulating exosomes, enriched with a group of tumor antigens, have been recognized as a promising biomarker source for cancer diagnosis via less invasive procedure. Quantitatively pinpointing exosome tumor markers is appealing, yet challenging. The sequential snapshots showing the release ...